Corcept Therapeutics Incorporated CORT

$ 55.81 -0.5%

Quarterly report 2024-Q3
added 10-30-2024

Corcept Therapeutics Incorporated Cash and Cash Equivalents 2011-2024 | CORT

Annual Cash and Cash Equivalents Corcept Therapeutics Incorporated

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
136 M	66.3 M	77.6 M	76.2 M	31.3 M	41.6 M	31.1 M	51.5 M	40.4 M	24.2 M	54.9 M	93 M	39.6 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
136 M	24.2 M	58.7 M

Quarterly Cash and Cash Equivalents Corcept Therapeutics Incorporated

2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
137 M	129 M	150 M	112 M	172 M	300 M	-	50.2 M	35.3 M	61.9 M	77.6 M	94.7 M	95.4 M	52.4 M	76.2 M	76.2 M	76.2 M	76.2 M	31.3 M	31.3 M	31.3 M	31.3 M	41.6 M	41.6 M	41.6 M	41.6 M	31.1 M	31.1 M	31.1 M	31.1 M	51.5 M	51.5 M	51.5 M	51.5 M	40.4 M	40.4 M	40.4 M	40.4 M	24.2 M	24.2 M	24.2 M	24.2 M	54.9 M	54.9 M	54.9 M	54.9 M	93 M	93 M	93 M	93 M	39.6 M	39.6 M	39.6 M	39.6 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
300 M	24.2 M	64.2 M